Harwood Advisory »

Crispr Therapeutics shares owned by Harwood Advisory

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Harwood Advisory from 13F filings

Historical chart of Harwood Advisory investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Harwood Advisory consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Harwood Advisory

Quarter filed Position value Share count Share price at filing
2024-09-30 $44k 925 46.98
2020-03-31 $18k 425 42.35

More positions owned by Harwood Advisory

Two Rds Shared Tr Anfield Unvl Etf (AFIF)
Vanguard World Mega Grwth Ind (MGK)
Ishares Tr Msci Eafe Etf (EFA)
Apple (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
First Tr Exchng Traded Fd Vi Tcw Unconstrai (UCON)
First Tr Exchange-traded Fst Low Oppt Eft (LMBS)
Vaneck Etf Trust Clo Etf (CLOI)
Pimco Etf Tr Active Bd Etf (BOND)
Ishares Msci Emrg Chn (EMXC)
Select Sector Spdr Tr Technology (XLK)
Vaneck Etf Trust Fallen Angel Hg (ANGL)
Ishares Tr 3 7 Yr Treas Bd (IEI)
Janus Detroit Str Tr B-bbb Clo Etf (JBBB)
First Tr Nas100 Eq Weighted SHS (QQEW)

View all positions for Harwood Advisory

Top funds holding Crispr Therapeutics

Capital Research and Management Company - Division 3
ARK Investment Management
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
BlackRock
BlackRock
T. Rowe Price Investment Management
State Street Corporation
Vanguard Group
NEA Management Company
Citadel Advisors
EcoR1 Capital
Susquehanna International
Bank of America Corporation
Sr One Capital Management

View all funds holding Crispr Therapeutics